Nexstim Plc (?Nexstim? or ?Company?) has received an order for an NBS System 5 from a healthcare services group based in the US. The system will mainly be used in neurosurgery for presurgical mapping of the brain.

Nexstim?s NBS (Navigated Brain Stimulation) System 5 is CE marked and FDA approved for presurgical mapping of the speech and motor cortices of the brain. In addition to its motor and speech mapping features, this specific system also includes therapeutic capabilities that allow the system to be used for the treatment of major depressive disorder (MDD).